Karl J Lackner
Investigation of Sudan IV staining areas in aortas of infants and children: possible prelesional stages of atherogenesis
Torzewski M, Navarro B, Cheng F, Canisius A, Schmidt T, Bhakdi S, Urban R, Lackner K. Investigation of Sudan IV staining areas in aortas of infants and children: possible prelesional stages of atherogenesis. Atherosclerosis 2009; 206:159-67.
Sep 1, 2009Investigation of Sudan IV staining areas in aortas of infants and children: possible prelesional stages of atherogenesis
Sep 1, 2009Atherosclerosis 2009; 206:159-67
Torzewski Michael, Navarro Bianca, Cheng Fei, Canisius Antje, Schmidt Talkea, Bhakdi Sucharit, Urban Reinhard, Lackner Karl J
Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo
Ostrau C, Hülsenbeck J, Herzog M, Schad A, Torzewski M, Lackner K, Fritz G. Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009
Jul 15, 2009Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo
Jul 15, 2009Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009
Ostrau Christian, Hülsenbeck Johannes, Herzog Melanie, Schad Arno, Torzewski Michael, Lackner Karl J, Fritz Gerhard
Endotoxin accelerates atherosclerosis independent of complement activation
Reifenberg K, Lackner K, Torzewski M, Zähringer U, Schaefer S, Sagban T, Küpper I, Wiese E, Koike T, Fan J, Lehr H, Bhakdi S. Endotoxin accelerates atherosclerosis independent of complement activation. Thrombosis research 2009; 123:653-8.
Feb 1, 2009Endotoxin accelerates atherosclerosis independent of complement activation
Feb 1, 2009Thrombosis research 2009; 123:653-8
Reifenberg Kurt, Lackner Karl J, Torzewski Michael, Zähringer Ulrich, Schaefer Stephan C, Sagban Tolga Atilla, Küpper Ines, Wiese Elena, Koike Tomonari, Fan Jianglin, Lehr Hans-Anton, Bhakdi Sucharit
Nitrate tolerance as a model of vascular dysfunction: roles for mitochondrial aldehyde dehydrogenase and mitochondrial oxidative stress
Daiber A, Oelze M, Wenzel P, Wickramanayake J, Schuhmacher S, Jansen T, Lackner K, Torzewski M, Münzel T. Nitrate tolerance as a model of vascular dysfunction: roles for mitochondrial aldehyde dehydrogenase and mitochondrial oxidative stress. Pharmacological reports : PR 2009; 61:33-48.
Jan 1, 2009Nitrate tolerance as a model of vascular dysfunction: roles for mitochondrial aldehyde dehydrogenase and mitochondrial oxidative stress
Jan 1, 2009Pharmacological reports : PR 2009; 61:33-48
Daiber Andreas, Oelze Matthias, Wenzel Philip, Wickramanayake Jennifer M Dias, Schuhmacher Swenja, Jansen Thomas, Lackner Karl J, Torzewski Michael, Münzel Thomas
Subendothelial infiltration of neutrophil granulocytes and liberation of matrix-destabilizing enzymes in an experimental model of human neo-intima
Dorweiler B, Torzewski M, Dahm M, Kirkpatrick C, Lackner K, Vahl C. Subendothelial infiltration of neutrophil granulocytes and liberation of matrix-destabilizing enzymes in an experimental model of human neo-intima. Thromb Haemost 2008; 99:373-81.
Feb 1, 2008Subendothelial infiltration of neutrophil granulocytes and liberation of matrix-destabilizing enzymes in an experimental model of human neo-intima
Feb 1, 2008Thromb Haemost 2008; 99:373-81
Dorweiler Bernhard, Torzewski Michael, Dahm Manfred, Kirkpatrick Charles James, Lackner Karl J, Vahl Christian-Friedrich
No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice
Torzewski M, Reifenberg K, Cheng F, Wiese E, Küpper I, Crain J, Lackner K, Bhakdi S. No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice. Thromb Haemost 2008; 99:196-201.
Jan 1, 2008No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice
Jan 1, 2008Thromb Haemost 2008; 99:196-201
Torzewski Michael, Reifenberg Kurt, Cheng Fei, Wiese Elena, Küpper Ines, Crain Jeanine, Lackner Karl J, Bhakdi Sucharit
Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice
Torzewski M, Münzel T, Förstermann U, Blankenberg S, Lehr H, Cheng F, Reifenberg K, Tsimikas S, Rossmann H, Li H, Daiber A, Oelze M, Kleschyov A, Ochsenhirt V, Lackner K. Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2007; 27:850-7.
Apr 1, 2007Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice
Apr 1, 2007Arterioscler Thromb Vasc Biol 2007; 27:850-7
Torzewski Michael, Münzel Thomas, Förstermann Ulrich, Blankenberg Stefan, Lehr Hans-Anton, Cheng Fei, Reifenberg Kurt, Tsimikas Sotirios, Rossmann Heidi, Li Huige, Daiber Andreas, Oelze Matthias, Kleschyov Andrei L, Ochsenhirt Viola, Lackner Karl J
Early diagnosis of Acanthamoeba infection during routine cytological examination of cerebrospinal fluid
Petry F, Bhakdi S, Werhahn K, Zöller L, Michel R, Walochnik J, Scheid P, Wilhelm-Schwenkmezger T, Bohl J, Torzewski M, Lackner K. Early diagnosis of Acanthamoeba infection during routine cytological examination of cerebrospinal fluid. J Clin Microbiol 2006; 44:1903-4.
May 1, 2006Early diagnosis of Acanthamoeba infection during routine cytological examination of cerebrospinal fluid
May 1, 2006J Clin Microbiol 2006; 44:1903-4
Petry Franz, Bhakdi Sucharit, Werhahn Konrad J, Zöller Lothar, Michel Rolf, Walochnik Julia, Scheid Patrick, Wilhelm-Schwenkmezger Thomas, Bohl Jürgen, Torzewski Michael, Lackner Karl J
Initiation and progression of atherosclerosis--enzymatic or oxidative modification of low-density lipoprotein?
Torzewski M, Lackner K. Initiation and progression of atherosclerosis--enzymatic or oxidative modification of low-density lipoprotein?. Clin Chem Lab Med 2006; 44:1389-94.
Jan 1, 2006Initiation and progression of atherosclerosis--enzymatic or oxidative modification of low-density lipoprotein?
Jan 1, 2006Clin Chem Lab Med 2006; 44:1389-94
Torzewski Michael, Lackner Karl J
A novel in vitro model for the study of plaque development in atherosclerosis
Dorweiler B, Torzewski M, Dahm M, Ochsenhirt V, Lehr H, Lackner K, Vahl C. A novel in vitro model for the study of plaque development in atherosclerosis. Thromb Haemost 2006; 95:182-9.
Jan 1, 2006A novel in vitro model for the study of plaque development in atherosclerosis
Jan 1, 2006Thromb Haemost 2006; 95:182-9
Dorweiler Bernhard, Torzewski Michael, Dahm Manfred, Ochsenhirt Viola, Lehr Hans-Anton, Lackner Karl J, Vahl Christian-Friedrich
Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?
Reifenberg K, Blettner M, Husmann M, Lackner K, Torzewski M, Samols D, Black S, Schaefer S, Wiese E, Baskal D, Lehr H, Bhakdi S. Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?. Arterioscler Thromb Vasc Biol 2005; 25:1641-6.
Aug 1, 2005Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?
Aug 1, 2005Arterioscler Thromb Vasc Biol 2005; 25:1641-6
Reifenberg Kurt, Blettner Maria, Husmann Matthias, Lackner Karl J, Torzewski Michael, Samols David, Black Steven, Schaefer Stephan C, Wiese Elena, Baskal Daniela, Lehr Hans-Anton, Bhakdi Sucharit
Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study
Schnabel R, Münzel T, Tiret L, Cambien F, Bickel C, Lubos E, Torzewski M, Espinola-Klein C, Rupprecht H, Lackner K, Blankenberg S. Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study. J Am Coll Cardiol 2005; 45:1631-7.
May 17, 2005Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study
May 17, 2005J Am Coll Cardiol 2005; 45:1631-7
Schnabel Renate, Münzel Thomas, Tiret Laurence, Cambien François, Bickel Christoph, Lubos Edith, Torzewski Michael, Espinola-Klein Christine, Rupprecht Hans J, Lackner Karl J, Blankenberg Stefan
Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization
Torzewski M, Shaw P, Han K, Shortal B, Lackner K, Witztum J, Palinski W, Tsimikas S. Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization. Arterioscler Thromb Vasc Biol 2004; 24:2307-12.
Dec 1, 2004Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization
Dec 1, 2004Arterioscler Thromb Vasc Biol 2004; 24:2307-12
Torzewski Michael, Shaw Peter X, Han Kyoo-Rok, Shortal Brian, Lackner Karl J, Witztum Joseph L, Palinski Wulf, Tsimikas Sotirios
Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis
Torzewski M, Bhakdi S, Gerl V, Husmann M, Han S, Schmitt A, Ochsenhirt V, Spath L, Paprotka K, Suriyaphol P, Lackner K. Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis. Arterioscler Thromb Vasc Biol 2004; 24:2130-6.
Nov 1, 2004Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis
Nov 1, 2004Arterioscler Thromb Vasc Biol 2004; 24:2130-6
Torzewski Michael, Bhakdi Sucharit, Gerl Verena B, Husmann Matthias, Han Shan-Rui, Schmitt Andrea, Ochsenhirt Viola, Spath Lena, Paprotka Kerstin, Suriyaphol Prapat, Lackner Karl J
Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence
Bhakdi S, Torzewski M, Paprotka K, Schmitt S, Barsoom H, Suriyaphol P, Han S, Lackner K, Husmann M. Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence. Circulation 2004; 109:1870-6.
Apr 20, 2004Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence
Apr 20, 2004Circulation 2004; 109:1870-6
Bhakdi Sucharit, Torzewski Michael, Paprotka Kerstin, Schmitt Steffen, Barsoom Hala, Suriyaphol Prapat, Han Shan-Rui, Lackner Karl J, Husmann Matthias
Beyond cholesterol: the enigma of atherosclerosis revisited
Bhakdi S, Lackner K, Han S, Torzewski M, Husmann M. Beyond cholesterol: the enigma of atherosclerosis revisited. Thromb Haemost 2004; 91:639-45.
Apr 1, 2004Beyond cholesterol: the enigma of atherosclerosis revisited
Apr 1, 2004Thromb Haemost 2004; 91:639-45
Bhakdi Sucharit, Lackner Karl J, Han Shan-Rui, Torzewski Michael, Husmann Matthias
Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease
Blankenberg S, Lackner K, Meyer J, Cambien F, Smieja M, Tiret L, Hafner G, Torzewski M, Bickel C, Rupprecht H, AtheroGene Investigators. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 2003; 349:1605-13.
Oct 23, 2003Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease
Oct 23, 2003N Engl J Med 2003; 349:1605-13
Blankenberg Stefan, Lackner Karl J, Meyer Jürgen, Cambien François, Smieja Marek, Tiret Laurence, Hafner Gerd, Torzewski Michael, Bickel Christoph, Rupprecht Hans J, AtheroGene Investigators
The combination of different antiphospholipid antibody subgroups in the sera of patients with autoimmune diseases is a strong predictor for thrombosis. A retrospective study from a single center
von Landenberg P, Schölmerich J, von Kempis J, Lackner K. The combination of different antiphospholipid antibody subgroups in the sera of patients with autoimmune diseases is a strong predictor for thrombosis. A retrospective study from a single center. Immunobiology 2003; 207:65-71.
Jan 1, 2003The combination of different antiphospholipid antibody subgroups in the sera of patients with autoimmune diseases is a strong predictor for thrombosis. A retrospective study from a single center
Jan 1, 2003Immunobiology 2003; 207:65-71
von Landenberg Philipp, Schölmerich Jürgen, von Kempis Johannes, Lackner Karl J